We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FN icon
151
Fabrinet
FN
$13.4B
$10.8M 0.14%
19,266
-11,660
-38% -$7.51M
NEE icon
152
NextEra Energy
NEE
$169B
$10.6M 0.14%
120,251
+4,737
+4% +$428K
ORIC icon
153
Oric Pharmaceuticals
ORIC
$1.28B
$10.3M 0.14%
954,768
+1,317
+0.1% +$11.9K
CRWV
154
CoreWeave
CRWV
$44.6B
$9.86M 0.13%
+99,209
New +$10.7M
AXP icon
155
American Express
AXP
$219B
$9.65M 0.13%
28,475
-8,489
-23% -$2.72M
HUBS icon
156
HubSpot
HUBS
$12.1B
$9.41M 0.13%
51,521
-31,430
-38% -$6.57M
DRUG
157
Bright Minds Biosciences
DRUG
$591M
$9.13M 0.12%
130,013
– –
ANET icon
158
Arista Networks
ANET
$243B
$8.66M 0.12%
51,343
+9,726
+23% +$1.53M
ANL
159
Adlai Nortye Group ADS
ANL
$966M
$8.27M 0.11%
+718,747
New +$8.75M
CSCO icon
160
Cisco
CSCO
$434B
$7.87M 0.11%
+66,888
New +$7M
ENB icon
161
Enbridge
ENB
$106B
$7.81M 0.1%
141,014
+37,293
+36% +$2.05M
SO icon
162
Southern Company
SO
$98.9B
$7.74M 0.1%
80,367
+9,934
+14% +$935K
RF icon
163
Regions Financial
RF
$25.3B
$7.41M 0.1%
244,646
+62,012
+34% +$1.74M
EHC icon
164
Encompass Health
EHC
$12B
$7.32M 0.1%
72,385
+2,083
+3% +$216K
KARD
165
Kardigan Inc
KARD
$1.74B
$7.16M 0.1%
+300,000
New +$6.94M
LLY icon
166
Eli Lilly
LLY
$1.01T
$6.81M 0.09%
5,596
+475
+9% +$485K
DUK icon
167
Duke Energy
DUK
$91.8B
$6.63M 0.09%
51,662
+12,150
+31% +$1.53M
AEP icon
168
American Electric Power
AEP
$65.7B
$6.5M 0.09%
47,083
+10,126
+27% +$1.33M
TRP icon
169
TC Energy
TRP
$63.6B
$6.3M 0.08%
90,997
+23,620
+35% +$1.56M
INBX icon
170
Inhibrx
INBX
$1.55B
$5.83M 0.08%
+61,545
New +$6.17M
COP icon
171
ConocoPhillips
COP
$170B
$5.33M 0.07%
51,146
+13,699
+37% +$1.62M
SPGI icon
172
S&P Global
SPGI
$122B
$5.05M 0.07%
12,389
-1,373
-10% -$580K
UNP icon
173
Union Pacific
UNP
$169B
$4.73M 0.06%
17,375
+2,798
+19% +$735K
QCOM icon
174
Qualcomm
QCOM
$201B
$4.33M 0.06%
22,997
+15,993
+228% +$2.99M
ADP icon
175
Automatic Data Processing
ADP
$110B
$3.26M 0.04%
14,495
+9,531
+192% +$2.04M
5 6
7
8 9

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.